Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CD44 | P16070 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.35 |
| ▸ | AKT1 | P31749 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL25315101 | 0.98 | PARP1 (0.55) | PARP1LMNAMAPTALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL31009377 | 0.98 | PARP1 (0.55) | PARP1LMNAMAPTALDH1A1HPGD | |
| SCHEMBL6584391 | 0.88 | PARP1 (0.44) | PARP1LMNAMAPTALDH1A1HPGD | |
| SCHEMBL29509042 | 0.88 | PARP1 (0.44) | PARP1LMNAMAPTALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL30378456 | 0.86 | PARP1 (0.43) | PARP1LMNAMAPTALDH1A1HPGD | |
| SCHEMBL2061156 | 0.86 | PARP1 (0.43) | PARP1LMNAMAPTALDH1A1HPGD | |
| SCHEMBL30051454 | 0.79 | PARP1 (0.41) | PARP1LMNAMAPTDAODYRK1A | |
| SCHEMBL19582237 | 0.75 | CD44 (0.51) | CD44 | |
| SCHEMBL13635655 | 0.74 | PARP1 (0.52) | PARP1SLC6A2SLC6A4KCNH2HRH1 | |
| SCHEMBL2007697 | 0.74 | PARP1 (0.52) | PARP1SLC6A2SLC6A4KCNH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12448360-B2 | Synthesis method for preparing SGLT inhibitor intermediate | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2025-10-21 | — | — | US | claimed |
| EP-4212520-B1 | SYNTHESIS METHOD FOR PREPARING SGLT INHIBITOR INTERMEDIATES | DAEWOONG PHARMACEUTICAL CO LTD (KR) | 2025-08-13 | — | — | EP | claimed |
| US-20230322699-A1 | SYNTHESIS METHOD FOR PREPARING SGLT INHIBITOR INTERMEDIATE | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2023-10-12 | — | — | US | claimed |
| CN-112094253-B | Synthetic method for preparing SGLT inhibitor intermediate | 株式会社大熊制药 | 2023-01-10 | — | — | CN | claimed |
| US-4647677-A | Process for preparing 2,3-dihydro-7-aminobenzofurans | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1987-03-03 | — | — | US | claimed |
| JP-7126881-A | — | — | None | — | — | JP | disclosed |
| EP-4695244-A1 | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES | Syngenta Crop Protection AG (CH) | 2026-02-18 | — | — | EP | disclosed |
| US-12448360-B2 | Synthesis method for preparing SGLT inhibitor intermediate | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2025-10-21 | — | — | US | disclosed |
| US-12448360-B2 | Synthesis method for preparing SGLT inhibitor intermediate | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2025-10-21 | — | — | US | disclosed |
| US-12391663-B2 | Isoindolinone compounds | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-19 | — | — | US | disclosed |
| EP-4212520-B1 | SYNTHESIS METHOD FOR PREPARING SGLT INHIBITOR INTERMEDIATES | DAEWOONG PHARMACEUTICAL CO LTD (KR) | 2025-08-13 | — | — | EP | disclosed |
| US-12358879-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-07-15 | — | — | US | disclosed |
| US-4647677-A | Process for preparing 2,3-dihydro-7-aminobenzofurans | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1987-03-03 | — | — | US | disclosed |
| US-4514211-A | HERBICIDES, PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-04-30 | — | — | US | disclosed |
| EP-0138280-A2 | Blood-pressure lowering piperazine derivatives | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1985-04-24 | — | — | EP | disclosed |
| EP-0048040-B1 | 7-SUBSTITUTED 2,3-DIHYDROBENZOFURANS, THEIR PREPARATION AND THEIR USE AS PESTICIDES OR AS CHEMICAL INTERMEDIATES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1984-08-29 | — | — | EP | disclosed |
| EP-0079683-A2 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-05-25 | — | — | EP | disclosed |
| EP-0048040-A1 | 7-Substituted 2,3-dihydrobenzofurans, their preparation and their use as pesticides or as chemical intermediates | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1982-03-24 | — | — | EP | disclosed |
| US-4302592-A | Pesticidal 3-(2,3-dihydrobenzofuran-7-yl)-5-methoxy-1,3,4-oxadiazol-2(3H)-one | SHELL OIL COMPANY (US) | 1981-11-24 | — | — | US | disclosed |
| US-3963717-A | ANTIINFLAMMATORY, ANALGESIC | SANDOZ, INC. (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12448360-B2 | Synthesis method for preparing SGLT inhibitor intermediate | SLC5A2, SLC5A1, SLC2A1 | PARP1 3375/4885LMNA 4377/4885MAPT 429/4885 |
| US-12391663-B2 | Isoindolinone compounds | CYP4F2, AOC2, AOC3 | PARP1 4554/4885LMNA 1164/4885MAPT 4795/4885 |
| US-12358879-B2 | Heterocyclic compound | PARK7, SMN1; SMN2, SNCA | PARP1 1873/4885LMNA 420/4885MAPT 44/4885 |
| US-20230322699-A1 | SYNTHESIS METHOD FOR PREPARING SGLT INHIBITOR INTERMEDIATE | SLC5A2, SLC5A1, SLC2A1 | PARP1 3375/4885LMNA 4377/4885MAPT 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.